» Articles » PMID: 26144316

The Utilization of Extracellular Proteins As Nutrients Is Suppressed by MTORC1

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2015 Jul 7
PMID 26144316
Citations 259
Authors
Affiliations
Soon will be listed here.
Abstract

Despite being surrounded by diverse nutrients, mammalian cells preferentially metabolize glucose and free amino acids. Recently, Ras-induced macropinocytosis of extracellular proteins was shown to reduce a transformed cell's dependence on extracellular glutamine. Here, we demonstrate that protein macropinocytosis can also serve as an essential amino acid source. Lysosomal degradation of extracellular proteins can sustain cell survival and induce activation of mTORC1 but fails to elicit significant cell accumulation. Unlike its growth-promoting activity under amino-acid-replete conditions, we discovered that mTORC1 activation suppresses proliferation when cells rely on extracellular proteins as an amino acid source. Inhibiting mTORC1 results in increased catabolism of endocytosed proteins and enhances cell proliferation during nutrient-depleted conditions in vitro and within vascularly compromised tumors in vivo. Thus, by preventing nutritional consumption of extracellular proteins, mTORC1 couples growth to availability of free amino acids. These results may have important implications for the use of mTOR inhibitors as therapeutics.

Citing Articles

Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses.

Lesbats J, Brillac A, Reisz J, Mukherjee P, Lhuissier C, Fernandez-Monreal M Nature. 2025; .

PMID: 40011782 DOI: 10.1038/s41586-025-08629-4.


Cooperative nutrient scavenging is an evolutionary advantage in cancer.

Guzelsoy G, Elorza S, Ros M, Schachtner L, Hayashi M, Hobson-Gutierrez S Nature. 2025; .

PMID: 39972131 DOI: 10.1038/s41586-025-08588-w.


Alcohol-induced C/EBP β-driven VIRMA decreases oxidative stress and promotes pancreatic ductal adenocarcinoma growth and metastasis via the m6A/YTHDF2/SLC43A2 pathway.

Gao L, Lv G, Liu Z, Tian Y, Han F, Li L Oncogene. 2025; .

PMID: 39900725 DOI: 10.1038/s41388-025-03283-6.


CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells.

Zhou S, Lin W, Jin X, Niu R, Yuan Z, Chai T Cell Rep Med. 2024; 5(12):101844.

PMID: 39637858 PMC: 11722114. DOI: 10.1016/j.xcrm.2024.101844.


Research advances in branched-chain amino acid metabolism in tumors.

Li Z, Chen S, Wu X, Liu F, Zhu J, Chen J Mol Cell Biochem. 2024; .

PMID: 39576465 DOI: 10.1007/s11010-024-05163-1.


References
1.
Manning B, Cantley L . AKT/PKB signaling: navigating downstream. Cell. 2007; 129(7):1261-74. PMC: 2756685. DOI: 10.1016/j.cell.2007.06.009. View

2.
Hingorani S, Wang L, Multani A, Combs C, Deramaudt T, Hruban R . Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005; 7(5):469-83. DOI: 10.1016/j.ccr.2005.04.023. View

3.
Kim E, Goraksha-Hicks P, Li L, Neufeld T, Guan K . Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol. 2008; 10(8):935-45. PMC: 2711503. DOI: 10.1038/ncb1753. View

4.
Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B . Bidirectional transport of amino acids regulates mTOR and autophagy. Cell. 2009; 136(3):521-34. PMC: 3733119. DOI: 10.1016/j.cell.2008.11.044. View

5.
Ma X, Blenis J . Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009; 10(5):307-18. DOI: 10.1038/nrm2672. View